VBCG
ABBV icon

Valley Brook Capital Group’s AbbVie ABBV Stock Holding History

Valley Brook Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.82M Buy
23,146
+183
+0.8% +$39.4K 3.3% 7
2026
Q1 		$4.99M Sell
22,963
-103
-0.4% -$22.8K 3.35% 6
2025
Q4 		$5.27M Buy
23,066
+146
+0.6% +$33.3K 3.49% 6
2025
Q3 		$5.31M Buy
22,920
+128
+0.6% +$26.1K 3.57% 6
2025
Q2 		$4.23M Sell
22,792
-125
-0.5% -$23.2K 3.17% 7
2025
Q1 		$4.8M Buy
22,917
+218
+1% +$42.4K 3.77% 3
2024
Q4 		$4.03M Sell
22,699
-88
-0.4% -$16.2K 3.01% 6
2024
Q3 		$4.5M Sell
22,787
-58
-0.3% -$10.8K 3.23% 4
2024
Q2 		$3.92M Buy
22,845
+96
+0.4% +$15.9K 3.05% 5
2024
Q1 		$4.14M Sell
22,749
-96
-0.4% -$16.5K 3.31% 4
2023
Q4 		$3.54M Buy
22,845
+128
+0.6% +$18.7K 3.08% 4
2023
Q3 		$3.39M Buy
22,717
+468
+2% +$68.7K 3.35% 4
2023
Q2 		$3M Sell
22,249
-891
-4% -$131K 2.77% 5
2023
Q1 		$3.69M Sell
23,140
-239
-1% -$36.5K 3.4% 4
2022
Q4 		$3.78M Buy
23,379
+357
+2% +$54.7K 3.62% 4
2022
Q3 		$3.09M Buy
23,022
+107
+0.5% +$15.4K 3.37% 5
2022
Q2 		$3.51M Sell
22,915
-400
-2% -$61.1K 3.62% 5
2022
Q1 		$3.78M Buy
23,315
+1,206
+5% +$175K 3.26% 4
2021
Q4 		$2.99M Buy
22,109
+208
+0.9% +$24.6K 2.58% 6
2021
Q3 		$2.36M Sell
21,901
-1,123
-5% -$128K 2.34% 9
2021
Q2 		$2.59M Buy
23,024
+627
+3% +$70.6K 2.47% 8
2021
Q1 		$2.42M Buy
22,397
+610
+3% +$65.2K 2.19% 8
2020
Q4 		$2.33M Buy
+21,787
New +$2.09M 2.31% 6

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Valley Brook Capital Group's ABBV Position: Q2 2026 in Review

Valley Brook Capital Group increased its AbbVie (ABBV) stake by 0.8% in Q2 2026, buying an estimated $39.4K and bringing the position to 23,146 shares worth $5.82M. The position accounts for 3.3% of the portfolio, ranked #7.

Valley Brook Capital Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Valley Brook Capital Group held 23,146 shares of AbbVie worth $5.82M as of Q2 2026.
  • Valley Brook Capital Group bought 183 AbbVie shares in Q2 2026, an estimated $39.4K.
  • AbbVie made up 3.3% of Valley Brook Capital Group's portfolio in Q2 2026, its #7 holding.
  • Valley Brook Capital Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.